Ceribell, Inc.CBLL财报
Nasdaq · 医疗保健 · 电子医疗与电疗设备
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| FMR LLC | 13.35% | 4.5M | — | 2024-11-07 |
| Longitude Capital Partners IV, LLC | 7.00% | 2.5M | — | 2024-10-22 |
内部人交易
Net 90d: −$3.54M · buys $55.2K / sells $3.59M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Xingjuan Chao | President and CEO | Sell (open market) | 14.0K | $18.40 | $257.6K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Option exercise | 1.4K | $4.70 | $6.8K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Sell (open market) | 1.4K | $18.40 | $26.6K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Option exercise | 23.6K | $4.70 | $110.7K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Sell (open market) | 23.6K | $18.40 | $433.4K |
| 2026-04-01 | Xingjuan Chao | President and CEO | Grant | 97.6K | $0.00 | $0 |
| 2026-04-01 | Manni Joseph S. | Chief Revenue Officer | Grant | 30.7K | $0.00 | $0 |
| 2026-04-01 | Raymond Woo | Chief Technology Officer | Option exercise | 1.5K | $2.24 | $3.3K |
| 2026-04-01 | Raymond Woo | Chief Technology Officer | Sell (open market) | 1.5K | $18.58 | $27.3K |
| 2026-04-01 | Raymond Woo | Chief Technology Officer | Option exercise | 3.0K | $4.70 | $14.2K |
1–10 of 58
第 1 页 / 共 6 页